Skip to main content
. Author manuscript; available in PMC: 2010 Jun 28.
Published in final edited form as: J Acquir Immune Defic Syndr. 2008 Nov 1;49(3):276–281. doi: 10.1097/QAI.0b013e318189a769

Table 1.

Antiretroviral Regimens Utilized in the Antenatal Clinic at Johannesburg General Hospital

Regimen Frequency (N) Percent
stavudine, lamivudine, efavirenz 47 7.6
stavudine, lamivudine, nevirapine 509 82
zidovudine, didanosine, ritonavir boosted lopinavir 1 0.2
Other: mixed nucleosides* and NNRTI 29 4.7
Other: mixed nucleosides* and PI 34 5.5
Total 620 100
*

Includes the following: stavudine, lamivudine, zidovudine, didanosine.

NNRTI: non-nucleoside reverse transcriptase inhibitor (nevirapine or efavirenz)

PI: protease inhibitor (ritonavir/lopinavir in kaletra capsule formulation)